Pneumocystis remains a common infection in patients with deficient CD4+ T-cell function. Analysis of murine and human models of the infection has revealed a critical for IL-21R, STAT3 signaling CD4+ T-cells as well as CD209 expressing macrophages. These data lead us to propose the hypothesis that IL-21R and STAT3 are required in a CD4+ T cell autonomous way to mount anti-Pneumocystis effector responses in the lung. Moreover we hypothesize that a major effector pathway regulated by this pathway is the recruitment of GM- CSFR+, high mannan binding (via expression of CD209 isoforms) and ?1,3 glucan binding (via Dectin-1) macrophages that mediate fungal clearance. We will test this hypothesis with the following Aims:
Specific Aim 1. Test the prediction that IL-21R and STAT3 are required in CD4+ T-cells to mediate resistance to Pneumocystis infection.
Specific Aim 2. Test the prediction that IL-21R and STAT3 control GM-CSF production which is critical for recruitment of fungicidal macrophages and fungal clearance.
Specific Aim 3. Test the prediction that CD4+ T-cells as well as IL-21R signaling facilitate fungal clearance by regulating the recruitment of fungicidal macrophage population that express GM-CSF receptors and c-type lectin receptors that bind and internalize fungi, namely Dectin-1 and CD209. These studies will be carried out in murine studies as well as translational human studies and will increase our understanding of the pathogeneses of this infection that will lead to new therapeutic and preventive strategies.

Public Health Relevance

Fungal infections such as Pneumocystis are a common complication of patients that do not have a strong immune system. We have identified a critical pathway that leads to the susceptibility of these types of infections and by understanding this pathway, this research could lead to new ways to prevent and treat this infection.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL062052-19
Application #
9049641
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Caler, Elisabet V
Project Start
1998-12-15
Project End
2020-01-31
Budget Start
2016-02-01
Budget End
2017-01-31
Support Year
19
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Pediatrics
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Eddens, Taylor; Elsegeiny, Waleed; Garcia-Hernadez, Maria de la Luz et al. (2017) Pneumocystis-Driven Inducible Bronchus-Associated Lymphoid Tissue Formation Requires Th2 and Th17 Immunity. Cell Rep 18:3078-3090
Chen, Kong; Kolls, Jay K (2017) Interluekin-17A (IL17A). Gene 614:8-14
Hoving, J Claire; Kolls, Jay K (2017) New advances in understanding the host immune response to Pneumocystis. Curr Opin Microbiol 40:65-71
Eddens, Taylor; Campfield, Brian T; Serody, Katelin et al. (2016) A Novel CD4+ T Cell-Dependent Murine Model of Pneumocystis-driven Asthma-like Pathology. Am J Respir Crit Care Med 194:807-820
Eddens, Taylor; Song, Eunkyung; Ardura, Monica I et al. (2016) A protracted course of Pneumocystis pneumonia in the setting of an immunosuppressed child with GMS-negative bronchoalveolar lavage. Med Mycol Case Rep 11:48-52
Kumar, Pawan; Monin, Leticia; Castillo, Patricia et al. (2016) Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation. Immunity 44:659-671
Elsegeiny, Waleed; Eddens, Taylor; Chen, Kong et al. (2015) Anti-CD20 antibody therapy and susceptibility to Pneumocystis pneumonia. Infect Immun 83:2043-52
Eddens, Taylor; Elsegeiny, Waleed; Nelson, Michael P et al. (2015) Eosinophils Contribute to Early Clearance of Pneumocystis murina Infection. J Immunol 195:185-93
Eddens, Taylor; Kolls, Jay K (2015) Pathological and protective immunity to Pneumocystis infection. Semin Immunopathol 37:153-62
Zheng, Mingquan; Cai, Yang; Eddens, Taylor et al. (2014) Novel pneumocystis antigen discovery using fungal surface proteomics. Infect Immun 82:2417-23

Showing the most recent 10 out of 44 publications